Teladoc Health, Inc.

NYSE:TDOC

Medical - Healthcare Information Services

Healthcare
$8.06 +2.57%

+$0.20 today

Market cap
$1.47B
Beta
2.14
P/E (TTM)
-8.1
EPS (TTM)
-$0.96
52W Low $4.40High $9.77

Volume 3.96M

Average 4.68M

TDOC Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Teladoc Health, Inc.NYSE: TDOC

Operating Expenses · Q1 FY2026 · quarter ended Mar 2026

Operating expenses declines year over year

Q1 FY2026 operating expenses of $372.76M fell 32.6% year over year, ahead of the -35.5% change in trailing-twelve-month operating expenses. Sequentially, it fell 22.5% from the prior quarter. Over 3 fiscal years it compounded at -49.1% a year.

Context

  • Operating expenses amounted to 79.9% of revenue in FY2025, down 30.6 pp from a year earlier.
  • Operating expenses increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -32.6% holds above the trailing-twelve-month pace of -35.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$372.76M-22.5% QoQ
Last fiscal yearDec 2025
$2.02B-28.8% YoY
LTMMar 2026
$1.84B-35.5% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-32.6%——
1 year-28.8%——
3-year CAGR-49.1%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
2.02B USD
Year-over-year change
-28.8%
4-year CAGR
+5.2%

Operating Expenses vs competitors

How TDOC compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -35.5% is the lowest of 11, against a peer median of +5.7%.
  • Operating expenses amounts to 73.2% of revenue for TDOC, versus a peer median of 67.1%.
TDOC Competitors
Operating Expenses for TDOC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TDOCTeladoc Health, Inc.LTM Mar 2026$1.84B USD-35.5%-49.1%73.2%
NVCRNovoCure LimitedLTM Mar 2026$690.48M USD+6.8%+7.8%102.4%
OMCLOmnicell, Inc.LTM Mar 2026$498.24M USD+4.1%-5.7%40.7%
AZTAAzenta, Inc.LTM Sep 2026$447.31M USD+59.0%+12.5%71.9%
PHRPhreesia, Inc.LTM Apr 2026$322.49M USD-4.5%-1.5%65.1%
IMNMImmunome, Inc.LTM Sep 2026$299.94M USD+54.6%+80.8%—
SDGRSchrödinger, Inc.LTM Sep 2026$291.15M USD-9.0%+7.7%108.2%
PGNYProgyny, Inc.LTM Jun 2026$209.96M USD+4.6%+15.0%16.0%
OMDAOmada HealthLTM Mar 2026$195.96M USD+29.8%+16.7%69.2%
PHVSPharvaris N.V.LTM Sep 2026€193.36M EUR+125.2%+25.1%—
EVOEvotec SELTM Mar 2026€189.23M EUR-24.8%+8.9%25.4%
Peer median (excluding TDOC) —+5.7%+10.7%67.1%

Competitors are the stored peer set for TDOC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.03B2.41B2.6B2.57B2.53B
Cost of Revenue650.26M743.99M760.03M751.27M771.59M
Gross Profit1.38B1.66B1.84B1.82B1.76B
Gross Margin68.0%69.1%70.8%70.8%69.5%
Research & Development311.88M333.63M348.52M307.27M277.92M
Selling, General & Admin1.11B1.3B1.37B1.35B1.09B
Operating Expenses1.65B15.32B2.09B2.84B2.02B
Depreciation & Amortization207.57M209.93M254.11M240.51M363.12M
EBITDA(31.42M)(7.54M)43.61M31.72M147.3M
EBITDA Margin-1.5%-0.3%1.7%1.2%5.8%
Operating Income(265.63M)(13.65B)(248.55M)(1.02B)(262.96M)
Operating Margin-13.1%-567.3%-9.6%-39.7%-10.4%
Interest Income776K12.67M46.78M57.07M36.77M
Interest Expense81.14M21.94M22.28M23.8M19.71M
Other Income / Expenses(119.03M)(10.13M)28.95M27.23M27.43M
Income Before Tax(384.66M)(13.66B)(219.61M)(993.65M)(235.53M)
Pre-Tax Margin-18.9%-567.7%-8.4%-38.7%-9.3%
Income Tax Expense44.14M(3.81M)760K7.59M(35.21M)
Net Income(428.79M)(13.66B)(220.37M)(1B)(200.32M)
Net Margin-21.1%-567.5%-8.5%-39.0%-7.9%
EPS (Basic)(2.73)(84.60)(1.36)(5.87)(1.14)
EPS (Diluted)(2.73)(84.60)(1.34)(5.87)(1.14)
Weighted Avg Shares156.94M161.46M162.17M170.56M176.22M
Weighted Avg Shares (Diluted)156.94M161.46M164.58M170.56M176.22M

Teladoc Health, Inc.

NYSE:TDOC

Intrinsic Alpha fair value

Locked

Current Price

$8.06

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.